Drugs / S5G4T-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03564119 | Jun 2018 → Jun 2019 | rosacea | Sol-Gel Technologies, Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S5G4T-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03564119 ↗ |
| Route | Topical | “topically apply S5G4T-1 cream” NCT03564119 ↗ |